Investing Profile
Mark Chin
Your Intro Paths to Mark Chin
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Mark Chin on
cbCurrent Investing Position
Arix Bioscience Managing Director
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
11
Mark Chin is on these Sector & Stage Rankings
Consumer Health (Series B)BioTech (Series B)Digital Health (Series B)Health IT (Series B)Health & Hospital Services (Series B)Digital Health (Seed)BioTech (Seed)BioTech (Series A)Consumer Health (Series A)Digital Health (Series A)Consumer Health (Seed)Consumer Health (Series B)Health IT (Series A)Health & Hospital Services (Seed)Health & Hospital Services (Series A)Health IT (Seed)Digital Health (Series B)BioTech (Series B)Consumer Health (Series A)Health & Hospital Services (Series B)Health IT (Series B)Consumer Health (Seed)Digital Health (Series A)BioTech (Series A)Health & Hospital Services (Series A)Health IT (Series A)Health & Hospital Services (Seed)Health IT (Seed)Digital Health (Seed)BioTech (Seed)New York City
Mark Chin's Investments On Record (8)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Evommune | Series BApr 2023$50M | $150M |
Ensoma | Series BJan 2023$85M | $210M |
Disc Medicine | Post Ipo EquityAug 2022$54M Post Ipo EquitySep 2021$90M | $260M |
VelosBio | Series BJul 2020$140M Series AOct 2018$58M  | $200M |
Imara | Series BMar 2019$63M | $63M |
Harpoon Therapeutics | Series CNov 2018$70M Series BMay 2017$45M | $120M |
Aura Biosciences | Series CDec 2017$30M | $130M |
Iterum Therapeutics | Series BMay 2017$65M | $110M |
Investors who invest with Mark Chin
Founders who looked at Mark Chin's profile also looked at these Scouts & Angels